BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Quantitative Structure-Activity Relationship

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Quantitative Structure-Activity Relationship:

Pubmed Logo
The anti-fibrillogenic activity of tetracyclines on PrP 106-126: a 3D-QSAR study.
There is evidence that Tetracyclines are potentially useful drugs to treat...
17th July, 2008
Dipartimento di Scienze dell'Ambiente e del Territorio, Universita degli J Mol Model. 2008 Jul 16;.
DOI Direct Link
Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein.
MOTIVATION: Insufficient knowledge of general principles for accurate...
17th July, 2008
Division of Viral Hepatitis and Biotechnology Core Facility, Division of Bioinformatics. 2008 Jul 15;.
DOI Direct Link
QSAR study of imidazoline antihypertensive drugs.
The hypotensive effect of imidazoline ligands was attributed to both...
16th July, 2008
Institute of Pharmaceutical Chemistry and Drug Analysis, Faculty of Bioorg Med Chem. 2008 Jun 28;.
DOI Direct Link
Flavonoids as Substrates and Inhibitors of Myeloperoxidase: Molecular Actions of Aglycone and Metabolites.
Myeloperoxidase (MPO), secreted by activated neutrophils and macrophages...
16th July, 2008
Chem Res Toxicol. 2008 Jul 12;.
DOI Direct Link
A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureas.
A linear quantitative structure-activity relationship (QSAR) model is...
16th July, 2008
Biomedical Sciences Research Center "Alexander Fleming", 34 Fleming Eur J Med Chem. 2008 Jul 9;.
DOI Direct Link

View more research publications.

Quantitative Structure-Activity Relationship Patents:

USPTO Logo
US Patent No.Title
7144553 Use of an array of polymeric sensors of varying thickness for detecting analytes in fluids
7189737 Cocaine receptor binding ligands
7196103 Indole derivatives as factor Xa inhibitors
7208521 Selective inhibitors of the urokinase plasminogen activator
7230027 Anti-first-pass effect compounds

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Quantitative Structure-Activity Relationship scientists - we have details of around 410 individuals working on Quantitative Structure-Activity Relationship .


This page has been viewed 162 times
Recent Search Terms used to find this page: structure activity relationship drug discovery | Membrane-Interaction Quantitative Structure-Activity Relationship MI-QSAR Analyses of Skin Penetration Enhancers | structure activity relationship of vitamin | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Quantitative Structure-Activity Relationship across BioPortfolio, or bestselling Quantitative Structure-Activity Relationship books or recently published Quantitative Structure-Activity Relationship books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional